{"id":"W4311500730","doi":"10.1016/j.pharmthera.2022.108330","title":"Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease","year":2022,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Fonds de Recherche du Québec - Santé","keywords":"Empagliflozin; Canagliflozin; Medicine; Dapagliflozin; Kidney disease; Diabetes mellitus; Population; Heart failure; Disease; Internal medicine; Pharmacology; Type 2 diabetes; Intensive care medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001420154,0.0006142071,0.001371317,0.0004052322,0.00008576133,0.0000139969,0.0002403993,0.0001427775,0.002911644],"category_scores_gemma":[0.000001144851,0.0004599463,0.0003478714,0.0003742566,0.000139303,0.00006783942,0.00007115884,0.0006698777,0.0000989708],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009401308,"about_ca_system_score_gemma":0.0008545779,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003391236,"about_ca_topic_score_gemma":0.000002250828,"domain_scores_codex":[0.9976873,0.0001912935,0.0005468797,0.0005895262,0.0003851909,0.0005997915],"domain_scores_gemma":[0.998902,0.0000715451,0.0002586666,0.0003706781,0.00002917748,0.0003679887],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006985737,0.003578809,0.01551259,0.01152151,0.00559349,0.0004554857,0.00009315308,0.000001588724,0.000001244044,0.000008300882,0.005276261,0.957259],"study_design_scores_gemma":[0.006751412,0.0007948665,0.001052018,0.00117646,0.02211717,0.000001042076,0.000002991485,0.000003819493,0.000006011227,0.000003226816,0.9677,0.0003909585],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001155994,0.992817,0.000001279954,0.0003085585,0.0008506061,0.004006147,0.0001966671,0.000100197,0.0005635173],"genre_scores_gemma":[0.0005974444,0.988256,0.00001441601,0.005595512,0.0002520291,0.001065341,0.003400463,0.0001400418,0.0006786889],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9624237,"threshold_uncertainty_score":0.9997852,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03482235961102632,"score_gpt":0.3352237035568663,"score_spread":0.3004013439458399,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}